Caricamento...
Immune checkpoint inhibitors for hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is a leading cause of cancer deaths worldwide, and advanced HCC generally caries a poor prognosis. The treatment of advanced disease is limited to sorafenib, which provides only a limited improvement in survival, and novel therapies are, thus, sorely needed. Among emer...
Salvato in:
| Pubblicato in: | Hepat Oncol |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Future Medicine Ltd
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6095178/ https://ncbi.nlm.nih.gov/pubmed/30191042 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/hep-2016-0004 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|